Public Company News

Yatsen Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

GUANGZHOU, China, April 12, 2022 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading Chinese beauty company, today announced that, it has received a letter from the New York Stock Exchange (the "NYSE") datedApril 11, 2022, notifying Yatsen that it is below co...

2022-04-12 19:30 3304

ChipMOS SCHEDULES FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL

HSINCHU, April 12, 2022 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT")...

2022-04-12 18:00 3148

Infineon to expand existing backend operations in Indonesia

MUNICH, April 12, 2022 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) expands its existing backend operations inIndonesia: PT Infineon Technologies Batam to purchase real estate from PT Unisem, a member of Unisem Group. The premises close to Infineon's existing backend manufac...

2022-04-12 17:53 4886

New Clinical Advisory Board to support PromarkerD global rollout

* Proteomics International establishes world class Clinical Advisory Board promarkerd.com/clinical-advisory-board * Comprises highly-respected physicians specialising in diabetes and kidney disease care fromthe United States, Europe and Austra...

2022-04-12 16:04 1889

CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States

CHENGDU, China, April 12, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that its new drug candidate CMG901 (the "Claudin 18.2 antibody drug conjugates") for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma has been granted the Orphan-drug Designation by t...

2022-04-12 15:45 1456

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued11-Apr-2022 over PR Newswire. ...

2022-04-12 15:34 2848

Autoliv launches multi-year commitment to support the UN Road Safety Fund

STOCKHOLM and NEW YORK and Usa, April 12, 2022 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, is supporting the United Nations Road Safety Fund (UNRSF) to strengthen insights into road safety challenges, contribute to safer mobility ...

2022-04-12 15:01 1593

Invitation to presentation of EQT AB's Q1 Announcement 2022

STOCKHOLM, April 12, 2022 /PRNewswire/ -- EQT AB's Q1 Announcement 2022 will be published on Tuesday26 April 2022 at approximately 07:30 CEST. EQT will host a conference call at08:30 CEST to present the report, followed by a Q&A session. The presentation and a video link for the webcast will be a...

2022-04-12 14:30 1412

LyondellBasell details path to 2030 in 2021 sustainability report

HOUSTON and ROTTERDAM, Netherlands, April 12, 2022 /PRNewswire/ -- LyondellBasell (NYSE: LYB) today announced the publication of its 2021 sustainability report: "Future Focused." The report details the company's ambitions to help end plastic waste in the environment, address climate change and s...

2022-04-12 14:00 3050

Trading platform moomoo and SUSS Investment Group Accelerate Youth Financial Literacy with Inaugural Investment Competition

* SUSS Investment Group partnered with moomoo on the Portfolio Management Challenge 2022, that saw undergraduates demonstrating their investing prowess. * Participants won attractive cash prizes of up to $5,000 while gaining valuable insights from industry experts, and working with real-time d...

2022-04-12 10:51 4222

ProstACT Update: TARGET Study Ethics Approval

MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its ProstACT TARGET Phase II clinical trial of the Company's prostate cancer antibody therapy candidate TLX591 (177Lu-DOTA-rosopatamab), in patients experiencing a fir...

2022-04-12 07:47 2032

Lakeshore Acquisition II Corp. Announces that Ordinary Shares, Rights and Warrants to Commence Separate Trading on or about April 14, 2022

NEW YORK, April 11, 2022 /PRNewswire/ -- Lakeshore Acquisition II Corp. (the "Company") (NASDAQ: LBBBU), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busin...

2022-04-12 04:15 2721

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA

SHANGHAI, April 11, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of HANSIZHUANG (serplulimab), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with chemotherapy for the first-line tr...

2022-04-11 22:07 3648

Angel Yeast's New Food Ingredients Smart Factory Enters Operation

YICHANG, China, April 11, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "the Company", 600298.SH), a listed global yeast and yeast extract manufacturer, is opening a new factory of food ingredients. The factory – loaded with state-of-the-art facilities th...

2022-04-11 21:52 3609

"XCMG Express" Departs to Belt and Road Initiative Destinations in Central Asia, Europe

XUZHOU, China, April 11, 2022 /PRNewswire/ -- XCMG (SHE:000425) has sent off three "XCMG Express" trains betweenMarch 28 to 30 from Xuzhou's railway freight center, the largest batch export delivery via land carriage in 2022 to date, with a total of 150 containers and machinery equipment valued a...

2022-04-11 21:11 2319

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for March 2022

CHENGDU, China, April 11, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina, as well as an operator of its own online ride-hailing platform, today announced the operati...

2022-04-11 21:00 1319

CBAK Energy to Report Fourth Quarter & Full year 2021 Unaudited Financial Results on Thursday, April 14, 2022

DALIAN, China, April 11, 2022 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it will report its unaudited financial results for the fourth quarter...

2022-04-11 21:00 1520

NetEase Games Developer Summit 2022 Event Begins on April 18

The NetEase Games Developer Summit 2022 event will be held from April 18-21. The event will bring together industry experts to share their knowledge and insights on a number of exciting video game development topics. GUANGZHOU, China, April 11, 2022 /PRNewswire/ -- NetEase Games, the online game...

2022-04-11 20:00 2007

Ping An Releases 2021 Sustainability Report

HONG KONG and SHANGHAI, April 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEx:2318; SSE:601318) has published its 2021 Sustainability Report. The sustainability report, the 13th from Ping An, highlights the Group's ...

2022-04-11 20:00 3725

PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), aclinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA ...

2022-04-11 20:00 1775